I have a terminal illness called cystic fibrosis. Here's why I don't have time for the Left's health care plans.

Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.

Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.

Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 millionRobust clinical pipeline with multibillion dollar opportunities and strong ...

Prime Medicine Inc. (NASDAQ:PRME) is one of the best biotech penny stocks to buy according to analysts. On December 23, ...

Shares of Krystal Biotech soar 57% in a year as strong Vyjuvek uptake and steady pipeline progress continue to push the stock higher.

In this week's Business Digest, staff promotions are announced for a local firm while a local hospital system is welcoming ...

The DWP says anyone whose condition has changed should report it as soon as possible. Those on the lower rate of £73.90 could ...

Latest DWP statistics reveal which health conditions are most likely to receive long-term Attendance Allowance payments ...

VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...

Cell and gene therapies use the body's building blocks - cells and genetic material - to boost the immune system or correct ...

Vitamin C is essential for immunity, energy, and overall health—but how much do you actually need, and when is ...